LRMR

Larimar Therapeutics, Inc. · Healthcare · Market cap $326.2M

Insiders bought $402K net in the last 90 days ·0 sellers, 9 buyers· latest Form 4 filed Nov 18, 2026

Insider Buying

$26.1M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

10

in the rolling window

Latest filing

Nov 18, 2026

Clayton Russell

Larimar Therapeutics, Inc. (LRMR) has 19 SEC Form 4 filings (22 transaction rows) in the rolling window, disclosed by 10 distinct insiders. Most recent filing: Nov 18, 2026.

Inside the rolling window, 10 insiders at Larimar Therapeutics, Inc. reported 14 open-market purchases totaling $26.1M and no open-market sales. The most active filer is Director Hamilton Thomas Edward with 3 filings. Insiders have net bought $569K over the trailing 6 months. The most recent open-market filing is a purchase of 3,322 shares by Chief Medical Officer Clayton Russell, dated Nov 16, 2026, worth $10K.

  • Industry:Biotechnology
  • CEO:Carole S. Ben-Maimon
  • Employees:71
  • HQ:Bala Cynwyd, PA, US
  • IPO:2014-06-19
Source
Clayton RussellFirst filing
Purchase$10KNov 18SEC ↗
SHERMAN JEFFREY WFirst in 9 months
Purchase$10KNov 16SEC ↗
Hamilton Thomas EdwardFirst in 4 months
Purchase$187KNov 13SEC ↗
Celano MichaelFirst filing
Purchase$50KNov 12SEC ↗
Shankar GopiFirst filing
Purchase$14KNov 12SEC ↗
Truitt JosephFirst filing
Purchase$10KNov 12SEC ↗
Harlow John B. Jr.First filing
Purchase$50KNov 12SEC ↗
THOMAS FRANK EFirst in 9 months
Purchase$22KNov 12SEC ↗
BEN-MAIMON CAROLEFirst filing
Purchase$50KNov 12SEC ↗
Hamilton Thomas EdwardFirst in 4 months
Purchase$167KJul 8SEC ↗
Flynn James EFirst in 3 months
Purchase$25.0MMar 2SEC ↗
THOMAS FRANK EFirst filing
Purchase$25KMar 2SEC ↗
SHERMAN JEFFREY WFirst filing
Purchase$25KMar 2SEC ↗
Purchase$500KMar 2SEC ↗
Showing 1–14 of 14
1 / 1

Frequently asked questions

How many SEC Form 4 insider filings does LRMR have?

Larimar Therapeutics, Inc. (LRMR) has 19 SEC Form 4 filings (22 transaction rows) in the rolling 365-day window, disclosed by 10 distinct insiders. Most recent filing: Nov 18, 2026.

When was the most recent SEC Form 4 filing for LRMR?

The most recent Form 4 filing for LRMR on Tracefour is dated Nov 18, 2026.

Who is the most active insider at LRMR?

The most active SEC Form 4 filer at LRMR in the rolling window is Director Hamilton Thomas Edward, with 3 filings.

What is the net insider flow at LRMR over the last 6 months?

Over the trailing 180 days, insiders at LRMR have net bought $569K based on SEC Form 4 disclosures.

What is the total insider buy and sell value at LRMR in the current window?

Inside the rolling window, insiders at LRMR bought $26.1M and sold $0 based on SEC Form 4 filings.

Can I get alerts for LRMR insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Larimar Therapeutics, Inc. (LRMR). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

Larimar Therapeutics, Inc. is in the Healthcare sector.